Pan Y - Search Results

1

MNK2 governs the macrophage antiinflammatory phenotype.

Bartish M, Tong D, Pan Y, Wallerius M, Liu H, Ristau J, de Souza Ferreira S, Wallmann T, van Hoef V, Masvidal L, Kerzel T, Joly AL, Goncalves C, Preston SEJ, Ebrahimian T, Seitz C, Bergh J, Pietras K, Lehoux S, Naldini L, Andersson J, Squadrito ML, Del Rincón SV, Larsson O, Rolny C. Bartish M, et al. Among authors: pan y. Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27556-27565. doi: 10.1073/pnas.1920377117. Epub 2020 Oct 19. Proc Natl Acad Sci U S A. 2020. PMID: 33077599 Free PMC article.

2

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8⁺ T cell recruitment.

Yang Z, Wang X, Fu Y, Wu W, Hu Z, Lin Q, Peng W, Pan Y, Wang J, Chen J, Hu D, Zhou Z, Xu L, Zhang Y, Hou J, Chen M. Yang Z, et al. Among authors: pan y. Mol Cancer. 2024 Sep 6;23(1):186. doi: 10.1186/s12943-024-02097-6. Mol Cancer. 2024. PMID: 39237909 Free PMC article.

3

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.

Zhou ZG, Chen JB, Zhang RX, Ye L, Wang JC, Pan YX, Wang XH, Li WX, Zhang YJ, Xu L, Chen MS. Zhou ZG, et al. Cancer Commun (Lond). 2020 Aug;40(8):355-369. doi: 10.1002/cac2.12069. Epub 2020 Jul 1. Cancer Commun (Lond). 2020. PMID: 32609436 Free PMC article.

4

Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trials.

Pan Y, Wang R, Hu D, Xie W, Fu Y, Hou J, Xu L, Zhang Y, Chen M, Zhou Z. Pan Y, et al. Front Biosci (Landmark Ed). 2021 Oct 30;26(10):873-881. doi: 10.52586/4994. Front Biosci (Landmark Ed). 2021. PMID: 34719212 Free article. Review.

5

ASO Author Reflections: Neoadjuvant Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin Is an Incredible Helper in Curing Patients with Intermediate-Advanced-Stage and Technically Resectable Hepatocellular Carcinoma.

Pan Y, Xu L. Pan Y, et al. Ann Surg Oncol. 2022 Mar;29(3):2030-2031. doi: 10.1245/s10434-021-11028-4. Epub 2021 Nov 5. Ann Surg Oncol. 2022. PMID: 34739640 No abstract available.

6

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis.

Pan YX, Fu YZ, Hu DD, Long Q, Wang JC, Xi M, Liu SL, Xu L, Liu MZ, Chen MS, Zhang YJ. Pan YX, et al. Front Oncol. 2020 Oct 29;10:1639. doi: 10.3389/fonc.2020.01639. eCollection 2020. Front Oncol. 2020. PMID: 33194569 Free PMC article.

7

Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.

Pan Y, Mei J, Chen J, Zhang D, Wang J, Wang X, Yi M, Zhou Z, Zhang Y, Chen M, Guo R, Xu L. Pan Y, et al. Ann Surg Oncol. 2022 Mar;29(3):2016-2029. doi: 10.1245/s10434-021-10903-4. Epub 2021 Oct 12. Ann Surg Oncol. 2022. PMID: 34637058

8

Lymph Node Ratio Rather Than Positive Lymph Node Counts Has Better Prognostic Value in Patients With Testicular Germ Cell Tumors.

Huang C, Long Q, Pan Y, Wu L, Wang X, Xu H, Zheng F. Huang C, et al. Among authors: pan y. Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820979702. doi: 10.1177/1533033820979702. Technol Cancer Res Treat. 2021. PMID: 33455540 Free PMC article.

9

Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy.

Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z. Zheng Z, et al. Among authors: pan y. J Hepatocell Carcinoma. 2023 Nov 30;10:2117-2132. doi: 10.2147/JHC.S436062. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38053944 Free PMC article.

10

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma.

Chen J, Fang A, Chen M, Tuoheti Y, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhu H, Zhang Y. Chen J, et al. Among authors: pan y. Cancer Med. 2018 Oct;7(10):5027-5035. doi: 10.1002/cam4.1787. Epub 2018 Sep 27. Cancer Med. 2018. PMID: 30259688 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,288 results

Search Page

Filters